The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis (2007)
- Authors:
- USP affiliated authors: NOGUEIRA, ANTONIO ALBERTO - FMRP ; FERRIANI, RUI ALBERTO - FMRP
- School: FMRP
- DOI: 10.1016/j.fertnstert.2006.02.082
- Subjects: ENDOMETRIOSE; CÁLCIO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Fertility and Sterility
- ISSN: 0015-0282
- Volume/Número/Paginação/Ano: v. 86, n. 3, sep. 2007
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Ana Carolina de Sá Rosa e; SILVA, Júlio César Rosa e; NOGUEIRA, Antonio Alberto; PETTA, Carlos Alberto; FERRIANI, Rui Alberto. The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis. Fertility and Sterility, New York, v. 86, n. 3, p. se 2007, 2007. DOI: 10.1016/j.fertnstert.2006.02.082. -
APA
Silva, A. C. de S. R. e, Silva, J. C. R. e, Nogueira, A. A., Petta, C. A., & Ferriani, R. A. (2007). The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis. Fertility and Sterility, 86( 3), se 2007. doi:10.1016/j.fertnstert.2006.02.082 -
NLM
Silva AC de SR e, Silva JCR e, Nogueira AA, Petta CA, Ferriani RA. The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis. Fertility and Sterility. 2007 ; 86( 3): se 2007. -
Vancouver
Silva AC de SR e, Silva JCR e, Nogueira AA, Petta CA, Ferriani RA. The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis. Fertility and Sterility. 2007 ; 86( 3): se 2007. - Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis
- Effects of the levonorgestrel releasing intra-uterine system on uterine and ovarian volumes, endometrial thickness and dopplervelocimetry of uterine arteries, in women with pelvic endometriosis
- Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Use of levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction
- Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue
- Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist
- Levonorgestrel intra-uterine device effects on endometriosis
- Comparative cell proliferation study in superficial and deep endometriotic lesions
- Increased expression of ID2, PRELP and SMOC2 genes in patients with endometriosis
Informações sobre o DOI: 10.1016/j.fertnstert.2006.02.082 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
